Together, the machine−learning importance ranking, tumor–normal contrasts across TCGA and GSE17558, and survival analyses converge on FAM189A2 as a protective hub within the risk framework, in line with its enrichment in the GPRC5A+ malignant subpopulation. This evidence concerns the gene GPRC5A and neoplasm.